← Back to Search

Arm 1 for Cancer

N/A
Waitlist Available
Led By Anna NA Tosteson, ScD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up tracking from time of study participation in educational intervention and following study participants for six months monitoring change in enrollment status in cancer research and clinical trials
Awards & highlights

Study Summary

This trial looks at how to best educate rural people in NH and VT about cancer research and clinical trials so that more people will enroll. Results will help researchers understand how education affects people's intentions and actions related to cancer research and clinical trials.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~tracking from time of study participation in educational intervention and following study participants for six months monitoring change in enrollment status in cancer research and clinical trials
This trial's timeline: 3 weeks for screening, Varies for treatment, and tracking from time of study participation in educational intervention and following study participants for six months monitoring change in enrollment status in cancer research and clinical trials for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent change in attitudes and behavioral intentions toward enrolling in clinical trials
Percent change in enrollment status in cancer research studies and clinical trials as measured by tracking individual enrollment statuses at the time of intervention and after education
Percent change in participant knowledge related to what cancer research studies and clinical trials are as assessed before and after educational intervention

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via a geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online follow-up.
Group II: Arm 1Experimental Treatment1 Intervention
Our study will be largely advertised to DCC's patients and caregivers via electronic provider portal BPA. Providers will provide prospective participants with a link to an online survey where they can consent, complete eligibility screening, the pretest, and contact information.

Find a Location

Who is running the clinical trial?

Dartmouth Cancer CenterUNKNOWN
1 Previous Clinical Trials
20 Total Patients Enrolled
Norris Cotton Cancer CenterOTHER
8 Previous Clinical Trials
1,526 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,447 Total Patients Enrolled

Media Library

Arm 1 Clinical Trial Eligibility Overview. Trial Name: NCT04409782 — N/A
Cancer Research Study Groups: Arm 1, Arm 2
Cancer Clinical Trial 2023: Arm 1 Highlights & Side Effects. Trial Name: NCT04409782 — N/A
Arm 1 2023 Treatment Timeline for Medical Study. Trial Name: NCT04409782 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Education About Health and Cancer Study
Judith R. Rees 2020. "Education About Health and Cancer Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04409782.
~50 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top